People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Pharmaceuticals, Other Technology, Retailing, Other, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | — | Pharmaceuticals | Series C | $192.5M | $611.8M | 2020 |
| Bluon, Inc. | — | Other Technology | Series B | $37.0M | $9.6M | 2021 |
| GT Spirits, Inc. | — | Retailing | Series B | $34.6M | $17.7M | 2021 |
| PharmaCielo Ltd. | — | Pharmaceuticals | Series A | $22.8M | $195.6M | 2018 |
| Ten Network Holdings Ltd | — | Other | Seed | $3.5M | $37.9M | 2012 |
| Alumier Group Holdings Ltd | — | Other | Seed | $1.1M | $19.5M | 2019 |
| Richer Pour, Inc. | — | Other | Pre-Seed | $603K | $13.9M | 2014 |
| Smart Packaging, LLC | — | Manufacturing | Pre-Seed | $100K | $1.5M | 2013 |
David Gordon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Gordon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Long | 1 | 11 |
| Ketan Patel | 1 | 10 |
| Albert Cha | 1 | 9 |
| ANAND MEHRA | 1 | 7 |
| Stephen Tullman | 1 | 7 |
| Paul Anderson | 1 | 5 |
| Neal Walker | 1 | 5 |
| Andrew Schiff | 1 | 5 |
| Maxine Gowen | 1 | 4 |
| Ryan Wilson | 1 | 4 |
| Richard Gordon | 1 | 4 |
| Devin Whatley | 1 | 4 |
| John McDonnell | 1 | 4 |
| Andrew A. Schiff | 1 | 3 |
| Andrew Powell | 1 | 3 |
| Christopher Powala | 1 | 3 |
| Kamil Ali-Jackson | 1 | 3 |
| Kenneth Phillippe | 1 | 3 |
| Joseph Monahan | 1 | 3 |
| David Yun | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.